Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Ritedose Corporation is a leading pharmaceutical contract development and manufacturing organization (CDMO) specializing in Blow-Fill-Seal (BFS) technology. Based in Columbia, South Carolina, the company focuses on the aseptic production of sterile unit-dose inhalation and ophthalmic products. In addition to its CDMO services, Ritedose operates a significant 503B outsourcing facility that provides ready-to-administer medications to hospitals and health systems. The company serves a global client base, ranging from small biotechs to major pharmaceutical corporations, and is a primary supplier of generic respiratory medications in the United States. In 2022, the company was acquired by Novo Holdings to further scale its sterile manufacturing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ritedose Pharmacy.